stockrow
Saturday 7 November 2026
Export NVNO’s income statement to Excel — free account
enVVeno Medical Corporation
NVNO Healthcare Medical Devices
- EPS
- +22.0%
- Free cash flow
- +27.6%
Quarter to September 2026, against a year earlier
6.39
0.58
−8.32%
Follow NVNO
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
13.30 | 11.63 | 11.39 | 7.13 | |
Current Ratio |
13.58 | 11.89 | 11.70 | 7.35 | |
Net Debt/EBITDA |
7.24 | 6.33 | 5.70 | 4.18 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.92 | 0.84 | 0.99 | 0.73 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.85) | (4.95) | (5.29) | (4.58) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(5.85) | (4.95) | (5.29) | (4.58) | |
Cash per Share |
47.90 | 38.12 | 32.02 | 26.62 | |
Shareholders Equity per Share |
46.06 | 36.31 | 30.80 | 24.35 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
46.06 | 36.31 | 30.80 | 24.35 | |
Free Cash Flow |
(3.44) | (3.24) | (3.55) | (3.18) | |
Working Capital |
26.70 | 23.35 | 20.20 | 16.43 | |
Capital Expenditures |
0.00 | — | — | — | |
Net Current Asset Value |
26.39 | 23.14 | 20.09 | 16.43 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | — | — | |
| Other line items | |||||
Average Payables |
1.73 | 1.52 | 2.06 | 2.15 | |
Average Assets |
37.26 | 33.34 | 29.62 | 25.92 | |
Average Common Equity |
34.64 | 31.03 | 26.86 | 23.17 |
Columns are period end dates · fundamentals updated 2 Nov 2026